Among active 13F managers last quarter, 8 opened and 7 added, while 7 reduced; the largest holder to move was Clearstead Advisors, LLC (+0.0%). Over the last 180 days, 2 insiders bought and 3 insiders sold, a net +$156K in open-market trades.
Funds lean in and no leg opposes.
76 tracked 13F filers disclose a position in MYO as of the latest SEC 13F filings, a combined $6.5M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Vanguard Capital Management LLC | 1.6M | $1.7M | ▲+43% Added · +492K sh | Q2 2026 | |
| 2 | Jefferies Financial Group Inc. | 704K | $732K | —Held | Q2 2026 | |
| 3 | Clearstead Advisors, LLC | 426K | $443K | ▲~0% Added · +9 sh | Q2 2026 | |
| 4 | Nuveen, LLC | 370K | $250K | —Held | Q1 2026 | |
| 5 | Geode Capital Management, LLC | 344K | $358K | ▼−60% Reduced · −514K sh | Q2 2026 | |
| 6 | AQR Capital Management LLC | 319K | $215K | ▼−27% Reduced · −115K sh | Q1 2026 | |
| 7 | UBS Group AG | 312K | $211K | ▼−44% Reduced · −248K sh | Q1 2026 | |
| 8 | LPL Financial LLC | 306K | $207K | ▲+73% Added · +129K sh | Q1 2026 | |
| 9 | Palumbo Wealth Management LLC | 300K | $312K | ▲Added Added · +300K sh | Q2 2026 | |
| 10 | BlackRock, Inc. | 223K | $232K | ▼−87% Reduced · −1.5M sh | Q2 2026 | |
| 11 | Northern Trust Corp | 214K | $145K | ▲+6.6% Added · +13K sh | Q1 2026 | |
| 12 | Vanguard Fiduciary Trust Co | 208K | $216K | ▼−12% Reduced · −30K sh | Q2 2026 | |
| 13 | Goldman Sachs Group Inc | 169K | $114K | ▼−66% Reduced · −330K sh | Q1 2026 | |
| 14 | Sei Investments Co | 148K | $100K | —Held | Q1 2026 | |
| 15 | Deutsche Bank AG | 136K | $92K | —Held | Q1 2026 | |
| 16 | IEQ Capital, LLC | 128K | $133K | ▲+278% Added · +94K sh | Q2 2026 | |
| 17 | State Street Corp | 106K | $110K | ▼−72% Reduced · −277K sh | Q2 2026 | |
| 18 | XTX Topco Ltd | 103K | $70K | ▼−36% Reduced · −59K sh | Q1 2026 | |
| 19 | Citadel Advisors LLC | 103K | $107K | ▲Added Added · +103K sh | Q2 2026 | |
| 20 | Centiva Capital, LP | 86K | $89K | ▲Added Added · +86K sh | Q2 2026 | |
| 21 | Charles Schwab Investment Management Inc | 82K | $55K | —Held | Q1 2026 | |
| 22 | Bank of New York Mellon Corp | 71K | $48K | ▼−0.2% Reduced · −118 sh | Q1 2026 | |
| 23 | Stratos Wealth Partners, LTD. | 60K | $62K | —Held | Q2 2026 | |
| 24 | New York State Common Retirement Fund | 45K | $30K | —Held | Q1 2026 | |
| 25 | Accel Wealth Management | 39K | $41K | ▲+14% Added · +5K sh | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 8 funds opened a new position in MYO and 7 added to an existing one, while 7 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Their position there |
|---|---|---|
| Nvidia CorpNVDA | 27 funds | $63.2B |
| Alphabet Inc-CL AGOOGL | 27 funds | $19.7B |
| Eli Lilly & CoLLY | 27 funds | $13.7B |
| Visa Inc-Class A SharesV | 27 funds | $11.2B |
| JPMorgan Chase & CoJPM | 27 funds | $9.4B |
| Unitedhealth Group IncUNH | 27 funds | $5.2B |
| Advanced Micro DevicesAMD | 27 funds | $5.2B |
| Chevron CorpCVX | 27 funds | $4.8B |
| Texas Instruments IncTXN | 27 funds | $4.0B |
| Intel CorpINTC | 27 funds | $4.0B |
| Abbott LaboratoriesABT | 27 funds | $3.6B |
| Boeing CoBA | 27 funds | $2.0B |
Ranked by how many of MYO's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in MYO.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Sep 2, 2026 | Morris Milton Mayo | Director | Sell (S) | 15K | $21K |
| Aug 20, 2026 | Kovelman Harry | Chief Medical Officer | Sell (S) | 18K | $30K |
| Jun 5, 2026 | Kirk Thomas F | Director | Buy (P) | 40K | $51K |
| May 28, 2026 | Kovelman Harry | Chief Medical Officer | Sell (S) | 12K | $12K |
| May 28, 2026 | Kirk Thomas F | Director | Buy (P) | 25K | $25K |
| May 27, 2026 | Kovelman Harry | Chief Medical Officer | Sell (S) | 20K | $21K |
| May 18, 2026 | Kirk Thomas F | Director | Buy (P) | 43K | $39K |
| May 15, 2026 | Manko Joseph M. Jr. | Director | Buy (P) | 30K | $27K |
| May 15, 2026 | Kirk Thomas F | Director | Buy (P) | 32K | $29K |
| May 14, 2026 | Mitchell Micah | Chief Commercial Officer | Sell (S) | 90K | $78K |
| May 14, 2026 | Manko Joseph M. Jr. | Director | Buy (P) | 171K | $147K |
| Mar 16, 2026 | Getz Heather C | Director | Buy (P) | 20K | $14K |
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 27 | 23 | – |
Insiders Form 4 open-market | 2 | 3 | +$156K |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
No filings captured for this ticker in the live stream yet.
Connected entities for MYO
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/MYO/capital-change-brief"
Use Arkolith's capital_change_brief for MYO. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for MYO. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.